SEC filing sparks speculation PE firm plans Medidata takeover
A SEC filing has created speculation that Medidata is the target of a private equity takeover attempt by Vista Equity Partners.
Archives for March 19, 2012
FDA 483 details 400 complaints that led to APP warning letter
The FDA has published a 483 detailing some of the 400 customer complaints that led to it sending a warning letter to APP Pharmaceuticals.
Indian clinical trial regulations still evolving, Parexel COO says
The Indian overhaul of clinical trial regulations is still evolving after a year of gains and setbacks, the Parexel COO said.
EMA wants Caelyx and Ceplene production moved away from Ben Venue Labs
More bad news for troubled CMO Ben Venue Laboratories after European regulators recommend that production of two more drugs – Caelyx and Ceplene – is relocated to other facilities.
Trade union brands Sanofi's UK plant closure "appalling"
The UK’s biggest trade union Unite has lashed out at Sanofi branding its plan to close a plant in Newcastle, England, as “unacceptable”.